ASSESSING FACTORS ASSOCIATED WITH OBSERVED LEVELS OF ADHERENCE TO ANTIRABIES PEP VACCINE AMONG ANIMAL BITE VICTIMS IN MACHAKOS LEVEL FIVE HOSPITAL
DOI:
https://doi.org/10.47672/ajhmn.30Keywords:
anti-rabies, pep vaccine, accessibility, adherence, awareness, machakos level 5 hospitalAbstract
Purpose: The purpose of this study was to determine factors associated with observed levels of adherence to ant rabies PEP vaccine among animal bite victims in Machakos level five hospital.
Methodology: The study used Cross sectional study design. It utilized both qualitative and quantitative methods. Data was collected by use of semi-structured questionnaires, physical examination sheet and key informant interview. The study population was victims of animal bites who revisited the health facility for the scheduled PEP vaccine. Random Sampling was used to select the revisiting animal bite victims until a sample size of 68 was achieved. Purposive sampling was used to select health care workers directly involved in management of animal bite victims until a sample size of three was achieved. Quantitative data was analyzed using SPSS version 20 and excel computer programs. Qualitative data was analyzed by content analysis. Binary logistic regression and multivariate regression was done.
Results: The study findings established that knowledge of rabies significantly affects the level of adherence to antirabies PEP vaccine. At least 48.50% of the respondents admitted that they have no knowledge of rabies and 75% had no knowledge of prevention of rabies. The study also found out that affordability of the cost of PEP vaccine is statistically associated with adherence to anti-rabies PEP vaccination.
Unique contribution to theory, practice and policy: The study concluded that: the level of adherence and the overall awareness not only of anti-rabies PEP vaccine, the follow-up of victims to check on the completion of the anti-rabies PEP vaccine schedule but also the management of wounds before visiting health facilities among animal bite victims in MKS L5 Hospital is low, thus a major public health concern both to the community and the county government.Downloads
References
Abotsi, E. I. (2012). Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana. International Journal of Tropical Disease and Health , 1-15.
Abuya, T.O, Mutemi,W., Karisa,B., Ochola,S.A., Fegan,G.& Marsh,V. (2007).Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions. Malar J, 6:57.
Ajayi, E. B. (2008). Effectiveness of artemisinin-based combination therapy used in context of home management of malaria: A report from three study sites in sub-Saharan Africa. Malaria Journal , 1 to 7.
Batwala, P. M. (2011). Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnostics : the implications for malaria control in Uganda. malaria Journal
CDC (2012). CDC-malaria. Retrieved May 04, 2012, from Centers for Disease Control and Prevention: www.cdc.gov
Chanda, B. H. (2011). Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale up of home-based management. Malaria Journal .
Chanda, P., Hamainza, B., Moonga, H. B., Chalwe, V., Banda, P., & Pagnoni, F. (2011). Relative costs and effectiveness of treating uncomplicated malaria in two rural districts in Zambia: implications for nationwide scale-up of home-based management. Malar J, 10(159), 151-152.
DOMC (2001). National Malaria Strategey 2001-2010 Ministry of Health, Kenya.
DOMC. (2010). 2010 Kenya Malaria Indicator Survey. Nairobi: Division of Malaria Control.
Goodman, C. A., Mutemi, W. M., Baya, E. K., Willetts, A. & Marsh, V. (2006). The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya. Health policy and planning, 21(4), 275-288.
Haddix, S. T. (2003). Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press.
Heymann, D. (2008). Control of communicable diseases manual. Washinton DC: United Book Press.
Kinfu, S. S.(2012). Therapeutic efficacy of Artemether-Lumefantrine for the Treatment of Uncomplicated Plasmodium falciparum Malaria In Northern Ethiopia. Malaria Research and Treatment , 1-6.
KRCS (2010). Beyond Prevention: Home management of malaria. Nairobi: Kenya Red Cross Society.
MOPHS (2011). Home Management of Malaria in Malindi and Lamu Districts, Coast Province. Nairobi: Ministry of Public Health and Sanitation.
Nonvignon, J., Chinbuah, M. A., Gyapong, M., Abbey, M., Awini, E., Gyapong, J. O. & Aikins, M. (2012). Is home management of fevers a cost‐effective way of reducing under‐five mortality in Africa? The case of a rural Ghanaian District. Tropical Medicine & International Health, 17(8), 951-957.
WHO (2000).The Abuja Declaration on Roll Back Malaria in Africa by the African Heads of States and Governments, 25th April, Abuja, Nigeria Geneva: WHO.
WHO (2004). Roll back malaria strategic framework for scaling up effective malaria case management . World Health organisation.
WHO (2005). The roll back malaria strategy for improving access to treatment through home management of malaria. WHO.
WHO (2011). World Malaria Report. WHO.
WHO (2012). Malaria Fact Sheet. World Health Organisation.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Alice N Gichohi, Dr. Yeri Kombe, Dr.Peter Mwaniki, Dr.Joseph Mutahi, Anne G Macharia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
